Radiopharmaceuticals Market Industry Analysis and Opportunity and Forecast to 2029
Data Bridge Market Research analyses that the radiopharmaceuticals market is expected to undergo a CAGR of 10.40% during the forecast period. This indicates that the market value, which was USD 4.80 billion in 2021, would rocket up to USD 11.69 billion by 2029. Nuclear medicine/ radiopharmaceuticals are increasingly being used in diagnostic imaging and radiotherapy. This has carved the way for the growth of the radiopharmaceutical market. Nuclear medicine/ radiopharmaceuticals assist in diagnosing the organs of any pathological condition, especially cancer. The huge development of nuclear imaging technologies, mainly PET/PET-CT, has helped to increase the field of uses for this modality from oncology to cardiology, neurology, and infection detection. Market Analysis and Insights WHO stated that cancer would be responsible for 10 million deaths globally in 2020. Furthermore, the American Cancer Society states that in the U.S., in 2020,...